Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines for unmet medical needs.
CNTA | US
Overview
Corporate Details
- ISIN(s):
- US1523091007
- LEI:
- Country:
- United States of America
- Address:
- 3RD FLOOR, ALTRINCHAM, CHESHIRE
- Website:
- https://www.centessa.com/
- Sector:
- Manufacturing
Description
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that utilizes a Research & Development innovation engine to discover and develop transformational medicines for patients. The company employs a data-driven approach to advance its portfolio of innovative assets. A key program in its pipeline is the development of potential best-in-class, orally administered orexin receptor 2 (OX2R) agonists for the treatment of sleep-wake disorders. Centessa's broader therapeutic focus often includes rare diseases and other areas with significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Centessa Pharmaceuticals plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Centessa Pharmaceuticals plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Centessa Pharmaceuticals plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
